top of page

38th annual meeting of the European Thyroid Association

Dr Steve Hyer presented a paper entitled “Clinical outcomes of Graves’ disease using a targeted absorbed dose of 60 Gy 131I to the thyroid.” Co-authors were B. Pratt, M. Gray, Dr Newbold, Dr Flux and Dr Harmer. The study reported the long term benefits of an individualized dose of radioiodine.

Featured Posts
Recent Posts
Search By Tags
No tags yet.
Follow Us
  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
bottom of page